Corning has announced a new line of microcarriers for large-scale vaccine and cell therapy manufacturing.
The microcarriers simplify the scale-up of attachment-dependent cells by providing a premeasured, sterile, ready-to-use product for direct transfer into bioreactors.
This single-step microcarrier solution replaces several steps traditionally required and allows researchers to minimise lab preparation time and enhance manufacturing results.
The new microcarriers offer Corning’s unique Synthemax II and Enhanced Attachment surface treatment options to maximise cell yield and viability.
They are fully compatible with closed systems solutions packaging in customisable batch sizes starting at 10g.
Further features include:
- Consistency - USP Class VI polystyrene material provides a consistent platform
- Performance - Corning Microcarriers are offered with two surface treatments
- Corning Synthemax II Coating- the unique Corning Synthemax II substrate creates a synthetic surface on the microcarriers for stem cell expansion
- Enhanced Attachment- Corning CellBIND Surface treatment infuses the surface of the microcarriers with oxygen to improve cell attachment
- Highest Sterility Assurance Level (SAL) of 10-6
- Certified nonpyrogenic
